Haoqian Zhang
张浩千
Haoqian Zhang is a synthetic biology entrepreneur and the co-founder and CEO of Bluepha (蓝晶微生物), a biotech company he established in 2016 with Tsinghua PhD Teng Li . He holds a bachelor's in biological sciences and a PhD in integrated life sciences (physics) from Peking University, and has published over 20 papers in top-tier academic journals . In 2019, he was named one of Fast Company's "Most Creative People in Business" in China (MCP100) . The company has been backed by FreeS Fund (峰瑞资本), which featured him in multiple investor events and research pieces through 2022 . elsewhere's corpus does not cover more recent developments.
AI-generated — may contain errors, please verify.
Coverage
The 6 Questions Young People Care About Most: We Asked 17 Founders | FreeS Fund Youth Festival & Graduation Season Special
Passion and conviction are what carry you through the darkness.
峰瑞资本·The U.S.-China Biotech Race: Where Are the Opportunities in Synthetic Biology? | FreeS Fund Dialogue
Over the next five to ten years, which technologies will have a significant impact on synthetic biology?
峰瑞资本·[Live Tomorrow] In Conversation with Bluepha | Synthetic Biology: From Groping in the Dark to Riding the Wave
Going live tomorrow at 10 a.m. sharp.
峰瑞资本·Untangling the Ins and Outs of Carbon Emissions to Find the Path to Carbon Neutrality | FreeS Research Institute
What Investment Opportunities Exist in the Hundred-Trillion-Yuan Carbon Neutrality Market?
峰瑞资本·How Should We Think About Green Investing? | FreeS Research Institute
Why Does Carbon Neutrality Have to Be Zero?
峰瑞资本·What Are the Opportunities for Biotech Over the Next Decade? | A FreeS Fund Conversation
Breaking Through the "Great Stagnation" in Technology: Biotechnology Is a Critical Breakthrough
峰瑞资本·4 Companies Raise Nearly 2 Billion RMB in Total | FreeS Family Funding News · Vol 8
Walk alongside more outstanding founders.
峰瑞资本·Synthetic Biology: The *Heavenly Crafts* of the Next Twenty Years | 2021 FreeS Fund Annual Investor Summit
How will the convergence of biotechnology and data science transform the production methods for over 60% of the world's physical goods?
峰瑞资本·Bluepha Closes RMB 40 Million Series A Round | FreeS Fund Deal Brief
Leading Global Engineered Microbe Development
峰瑞资本·Beauty Brands Entering China, Becoming India's Third-Largest E-Commerce Player, and Betting on Biomedical — 22 Developments and 5 Takeaways | FreeS Fund Bulletin · September
Do what's right, not what's easy.
峰瑞资本·Bluepha Completes Pre-A Round, Angel Investor FreeS Fund Continues to Follow On | FreeS Fund Investment News
Create more microbes to fully satisfy people's pursuit of a better life.
峰瑞资本·
![[Live Tomorrow] In Conversation with Bluepha | Synthetic Biology: From Groping in the Dark to Riding the Wave](/_next/image?url=https%3A%2F%2Fkkcktdhgzddmdjdjoenc.supabase.co%2Fstorage%2Fv1%2Fobject%2Fpublic%2Fmedia%2Fimages%2F45f83c6a-7c35-4040-ba2d-210c7948ac95%2Fd7061a92cbcc.jpg&w=384&q=75)
